Protagenic Therapeutics, Inc.\new Cash and Cash Equivalents, Period Increase (Decrease)
Protagenic Therapeutics, Inc.\new (PTIX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $56.85 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-16.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-16
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $56.85K.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$69.45K.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $195.92K, a 39.59% decline year-over-year.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$107.27K.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$37.20K.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$2.70M, a 187.20% decline from fiscal 2016.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for fiscal 2016 was $3.10M.
- Protagenic Therapeutics, Inc.\new cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$19.39K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $56.85K 10-Q · filed 2019-05-16 | -$12.60K derived: sum of 2 quarters · filed 2019-05-16 | $183.32K derived: sum of 3 quarters · filed 2019-05-16 | $76.05K derived: sum of 4 quarters · filed 2019-05-16 |
| 2018-12-31 | -$69.45K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $126.47K derived: sum of 2 quarters · filed 2019-03-29 | $19.20K derived: sum of 3 quarters · filed 2019-03-29 | -$37.20K 10-K · filed 2019-03-29 |
| 2018-09-30 | $195.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $88.64K derived: sum of 2 quarters · filed 2018-11-08 | $32.24K 10-Q · filed 2018-11-08 | -$520.20K derived: sum of 4 quarters · filed 2019-05-16 |
| 2018-06-30 | -$107.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$163.67K 10-Q · filed 2018-08-14 | -$716.12K derived: sum of 3 quarters · filed 2019-05-16 | -$391.81K derived: sum of 4 quarters · filed 2019-05-16 |
| 2018-03-31 | -$56.40K 10-Q · filed 2019-05-16 | -$608.85K derived: sum of 2 quarters · filed 2019-05-16 | -$284.54K derived: sum of 3 quarters · filed 2019-05-16 | -$2.40M derived: sum of 4 quarters · filed 2019-05-16 |
| 2017-12-31 | -$552.45K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$228.14K derived: sum of 2 quarters · filed 2019-03-29 | -$2.35M derived: sum of 3 quarters · filed 2019-03-29 | -$2.70M 10-K · filed 2019-03-29 |
| 2017-09-30 | $324.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$1.79M derived: sum of 2 quarters · filed 2018-11-08 | -$2.15M 10-Q · filed 2018-11-08 | -$2.54M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$2.47M 10-Q · filed 2018-08-14 | -$2.86M derived: sum of 3 quarters · filed 2018-08-14 | -$3.16M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$355.40K 10-Q · filed 2018-05-15 | -$743.98K derived: sum of 2 quarters · filed 2018-05-15 | -$1.04M derived: sum of 3 quarters · filed 2018-05-15 | -$1.01M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$388.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$687.79K derived: sum of 2 quarters · filed 2018-04-02 | -$650.37K derived: sum of 3 quarters · filed 2018-04-02 | $3.10M 10-K · filed 2018-04-02 |
| 2016-09-30 | -$299.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$261.79K derived: sum of 2 quarters · filed 2017-11-13 | $3.49M 10-Q · filed 2017-11-13 | $3.48M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $37.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $3.78M 10-Q · filed 2017-08-08 | $3.78M derived: sum of 3 quarters · filed 2017-08-08 | $3.73M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $3.75M 10-Q · filed 2017-05-15 | $3.74M derived: sum of 2 quarters · filed 2017-05-15 | $3.69M derived: sum of 3 quarters · filed 2017-05-15 | $3.69M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-03-11 | -$58.00K 10-Q · filed 2016-03-11 | -$53.47K derived: sum of 3 quarters · filed 2016-08-15 | -$19.39K 10-K/A · filed 2017-05-08 |
| 2015-09-30 | -$52.00K 10-Q · filed 2015-11-13 | -$47.47K derived: sum of 2 quarters · filed 2016-08-15 | $36.12K 10-Q · filed 2016-11-17 | -$30.39K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-06-30 | $4.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$17.39K 10-Q · filed 2016-08-15 | $21.61K derived: sum of 3 quarters · filed 2016-08-15 | -$39.00K 10-K · filed 2015-09-25 |
| 2015-03-31 | -$21.93K 10-Q · filed 2016-07-25 | $17.07K derived: sum of 2 quarters · filed 2016-07-25 | -$44.00K 10-Q · filed 2015-05-11 | -$59.92K derived: sum of 4 quarters · filed 2016-07-25 |
| 2014-12-31 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-03-11 | $49.00K 10-Q · filed 2016-03-11 | -$38.00K derived: sum of 3 quarters · filed 2016-03-11 | -$133.25K 8-K/A · filed 2016-07-12 |
| 2014-09-30 | $10.00K 10-Q · filed 2015-11-13 | -$77.00K derived: sum of 2 quarters · filed 2015-11-13 | -$18.00K derived: sum of 3 quarters · filed 2015-11-13 | -$169.00K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | -$28.00K derived: sum of 2 quarters · filed 2015-09-25 | -$179.00K derived: sum of 3 quarters · filed 2015-09-25 | -$616.00K 10-K · filed 2015-09-25 |
| 2014-03-31 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | -$92.00K derived: sum of 2 quarters · filed 2015-05-11 | -$529.00K 10-Q · filed 2015-05-11 | |
| 2013-12-31 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | -$588.00K 10-Q · filed 2015-02-06 | ||
| 2013-09-30 | -$437.00K 10-Q · filed 2014-11-13 | |||
| 2011-09-30 | -$311.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$4.32M 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | -$4.01M 10-Q/A · filed 2011-09-07 | |||
| 2010-09-30 | -$3.02M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$12.66M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$9.64M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |